Aug 27, 2018

Drug manufacturing companies in jeopardy!

It is reported that the country’s pharmaceutical companies are facing a situation where their operations could be affected. This is due to the failure of the Finance Ministry in paying them Rs. 20 billion in arrears payments. 

The companies that manufacture medicinal drugs in collaboration with the Health Ministry and the State Pharmaceutical Corporation are facing numerous problems due to this situation. 

Although the Health Ministry had sent several reminders to the Finance Ministry regarding this payment, so far no positive response has been received, it is reported.

Due to this situation there could be a shortage of locally manufactured medicines, it is said.

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.